Principle 4 : Duality (2)
Much of the debate on CRS in the past has dwelt in a polarized world of ‘either/or’. Either your company is responsible or it is not. Either you support GMOs or you don’t. Either you make life-saving drugs available for free or you don’t. This fails to recognize that most CRS 2.0 world, companies (and their critics) will have to become far more sophisticated in understanding local contexts and the appropriate local solutions they demand, without forsaking universal principles.